Background:The Ministry of Health is drafting a policy that aims at integrating health services delivery for people above 60 years within the existing delivery structures in Uganda. To inform their …
Dorsey G,
Kamya M R,
Bigira V,
Jagannathan P,
Nankya F,
Bowen K,
Eccles-James I,
Feeney M E,
Stoyanov C,
Sikyomu E
and others...
2015
Journal,
Article
Health Research
Background.âThe malaria-specific T-cell response is believed to be important for protective immunity. Antimalarial chemoprevention may affect this response by altering exposure to malaria antigens.Methods.âWe performed interferon γ (IFNγ) ELISpot assays …
Kamya M,
Greenhouse B,
Dorsey G,
Bigira V,
Aweeka F,
Jagannathan P,
Nankya F,
Bowen K,
Feeney M E,
Sikyomu E
and others...
2016
Journal,
Article
Health Research
Background.âExperimental inoculation of viable Plasmodium falciparum sporozoites administered with chemoprevention targeting blood-stage parasites results in protective immunity. It is unclear whether chemoprevention similarly enhances immunity following natural exposure to malaria.Methods.âWe …
Hospice Africa Uganda introduced palliative medicine to Uganda in 1993 with enough funds to support a team of three clinicians for three months. Training in the medical and nursing schools …
Abu-Raddad L.J.,
Adekanmbi V.,
Ahmadi K.,
Ahmed M.B.,
Akunna C.J.,
Alahdab F.,
Alanezi F.M.,
Alipour V.,
Andrei C.L.,
Andrei T.
and others...
2021
Journal,
Article
Health Research
Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time …
10 October 2009: My suitcase and computer backpack are ready, filled with a mosquito net; malaria tablets; camping cutlery; a headlamp; medevac papers; The Lonely Planet Guide to Uganda; The …
Kwarisiima D,
Kabami J,
Liegler T,
Chamie G,
Jain V,
Black D,
Thirumurthy H,
Kamya M R,
Clark T D,
Geng E H
and others...
2013
Journal,
Article
Health Research
Background. Population-based human immunodeï¬ciency virus type 1 (HIV-1) RNA levels (viral load [VL]) are proposed metrics for antiretroviral therapy (ART) program effectiveness. We estimated population-based HIV RNA levels using a …